Future regenerative therapies for corneal disease

John Y Lee1, Robert J Knight1, Sophie X Deng1,2

  • 1Stein Eye Institute, Department of Ophthalmology, David Geffen School of Medicine.

Abstract

Insights

Stem cell therapies show promise for treating corneal diseases by regenerating tissue and restoring function. These regenerative approaches offer an alternative to traditional surgeries, advancing corneal disease treatment.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Corneal diseases represent a significant cause of visual impairment globally.
  • Traditional surgical treatments for corneal diseases have limitations and challenges.
  • Stem cell-based therapies offer a novel approach to corneal regeneration.

Approach:

  • This review summarizes the progress of stem cell-based regenerative therapies for corneal disease.
  • It covers the history, mechanisms, limitations, and future directions of these therapies.
  • Key stem cell-based approaches include limbal, stromal, and endothelial stem cell transplantation, as well as stem cell-derived extracellular vesicles.

Key Points:

  • Corneal stem cell-based therapies have shown promising preclinical and early clinical results.
  • These therapies aim to facilitate tissue regeneration and restore native corneal function.
  • Potential benefits include inhibiting fibrosis, inflammation, and neovascularization in corneal disease.

Conclusions:

  • Stem cell-based therapy presents a promising therapeutic option for corneal diseases.
  • It has the potential to overcome limitations associated with conventional surgical methods.
  • Further research and development are crucial for advancing these regenerative treatments.